Tech Investors

WRF Capital

WRF Capital is an investing group that provides funding to qaulifying tech sector companies.

Venture Investor Overview

Venture Investor
WRF Capital
Status
Active
Investor Type
Other
Activity Level
56 transactions
Funds Raised
Unknown
Industry Focus
Biopharmaceutical
Healthcare IT
Healthcare Services

Contact Information

Contact
Ronald Howell
Title
Chief Executive Officer
Mailing Address
2815 Eastlake Ave. East 300
Seattle, WA 98102
USA
Phone
(206) 336-5600
Website
www.wrfseattle.org
Email Address
[email protected]

Background Information

Overview
Washington Research Foundation (WRF) helps Washington State research institutions capture value from their emerging technologies, through intellectual property management and start-up investment activities. From its licensing successes, WRF built a seed venture fund, WRF Capital to invest in local private technology companies. WRF Capital's gains are used to support research and entrepreneurship at Washington State research institutions.
Profile
WRF Capital LinkedIn Company Profile
Social Media
WRF Capital Company Twitter Account
Company News
WRF Capital News
Facebook
WRF Capital on Facebook
YouTube
WRF Capital on YouTube
Last Transaction
2/1/2024

Transaction History

Our records indicate that WRF Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Proniras
2/1/2024
$4,650,000
AdaptX
11/1/2023
$10,000,000
KayoThera
7/19/2023
$5,200,000
Wavely Diagnostics
7/12/2023
$1,350,000
Somalytics
8/30/2022
$1,900,000
Wavely Diagnostics
2/17/2022
$2,200,000
BirchAI
1/28/2022
$3,100,000
AdaptX
7/29/2021
$6,000,000
Outpace Bio
4/1/2021
$30,000,000
ThruWave
9/7/2020
$6,400,000
WiBotic
6/12/2020
$5,700,000
AdaptX
5/26/2020
$1,100,000
Membrion
3/5/2020
$6,000,000
AbSci
1/15/2020
$15,400,000
AbSci
5/31/2018
$12,000,000
Proniras
4/30/2018
Unknown
Arzeda
11/29/2017
$3,200,000
Rodeo Therapeutics
7/26/2017
$5,900,000
Arzeda
7/21/2017
$12,000,000
Phytelligence
7/6/2017
$7,000,000
WiBotic
4/27/2017
$2,500,000
ApoGen Biotechnologies
12/13/2016
$7,000,000
C-SATS
6/2/2015
$2,500,000
FlexMinder
3/25/2014
$1,200,000
Qazzow
12/17/2013
$2,400,000
Mobisante
6/30/2013
$4,151,000
Cardeas Pharma
5/23/2013
$34,000,000
FlexMinder
1/31/2013
$1,400,000
Resolve Therapeutics
11/1/2012
$5,800,000
Alder Biopharmaceuticals
4/19/2012
$38,000,000
Uptake Medical
3/31/2012
$5,158,300
Cardeas Pharma
12/20/2011
$5,000,000
Groove Biopharma
12/12/2011
$6,000,000
Acylin Therapeutics
6/30/2011
$2,399,900
Oncofactor
5/25/2011
$2,100,000
Acylin Therapeutics
12/31/2010
$1,999,900
Skytap
12/31/2010
$9,999,997
Uptake Medical
7/7/2010
$17,500,000
MicroGreen Polymers
5/19/2010
$6,900,000
Groove Biopharma
4/26/2010
Unknown
GlobeImmune
3/31/2010
$17,508,500
MicroGreen Polymers
7/9/2009
$1,600,000
XORI
6/30/2009
$2,101,800
Modumetal
5/29/2009
$1,500,000
Pathway Medical Technologies
5/20/2009
$42,500,000
Arzeda
2/27/2009
$12,000,000
Corensic
1/21/2009
$1,500,000
Groove Biopharma
9/30/2008
$3,634,000
Nimbic
9/30/2008
$2,525,000
Recodagen
9/30/2008
$600,000
Nimbic
1/30/2008
$2,500,000
Alder Biopharmaceuticals
1/11/2008
$40,000,000
GlobeImmune
9/26/2007
$41,200,000
Hyperion Therapeutics
9/5/2007
$40,000,000
Skytap
8/13/2007
$6,000,000
Alder Biopharmaceuticals
8/15/2005
$11,100,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
William Canestaro
  William Canestaro LinkedIn Profile  William Canestaro Twitter Account  William Canestaro News  William Canestaro on Facebook
Chief Executive Officer
Ronald Howell
  Ronald Howell LinkedIn Profile  Ronald Howell Twitter Account  Ronald Howell News  Ronald Howell on Facebook
Managing Director
Loretta Little
  Loretta Little LinkedIn Profile  Loretta Little Twitter Account  Loretta Little News  Loretta Little on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

WRF Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
AbSci
Acylin Therapeutics
AdaptX
Alder Biopharmaceuticals
ApoGen Biotechnologies
Arzeda
BirchAI
C-SATS
Cardeas Pharma
Corensic
FlexMinder
GlobeImmune
Groove Biopharma
Hyperion Therapeutics
KayoThera
Membrion
MicroGreen Polymers
Mobisante
Modumetal
Nimbic
Oncofactor
Outpace Bio
Pathway Medical Technologies
Phytelligence
Proniras
Qazzow
Recodagen
Resolve Therapeutics
Rodeo Therapeutics
Skytap
Somalytics
ThruWave
Uptake Medical
Wavely Diagnostics
WiBotic
XORI

 

 

 

 

Browse more tech investors:

Worcester Polytechnic Institute | Yale University

 

Share this article

 

About Our Tech Company Investor Database

This tech investor profile is powered by VentureDeal.com, a leading provider of tech investor transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.